Skip to main content

Heart Failure Reviews

Ausgabe 2/2021

Inhalt (21 Artikel)

Cardiac contractility modulation for patient with refractory heart failure: an updated evidence-based review

Luigi Cappannoli, Roberto Scacciavillani, Erica Rocco, Francesco Perna, Maria Lucia Narducci, Marcello Vaccarella, Domenico D’Amario, Gemma Pelargonio, Massimo Massetti, Filippo Crea, Nadia Aspromonte

Drug development in oncology and devices—lessons for heart failure drug development and approval? a review

Beth A. Davison, Gad Cotter, Gerasimos S. Filippatos, Faiez Zannad, Adriaan A. Voors, Marco Metra, John R. Teerlink, Stefanie Senger, Alexandre Mebazaa, Barry Greenberg

Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings

Giulia Elena Mandoli, Carlotta Sciaccaluga, Francesco Bandera, Paolo Cameli, Roberta Esposito, Antonello D’Andrea, Vincenzo Evola, Regina Sorrentino, Alessandro Malagoli, Nicolò Sisti, Dan Nistor, Ciro Santoro, Elena Bargagli, Sergio Mondillo, Maurizio Galderisi, Matteo Cameli

A reappraisal of the pharmacologic management of gastrointestinal bleeding in patients with continuous flow left ventricular assist devices

Audrey J. Littlefield, Gregory Jones, Alana M. Ciolek, Melana Yuzefpolskaya, Douglas L. Jennings

Takotsubo cardiomyopathy with low ventricular ejection fraction and apical ballooning predicts mortality: a systematic review and meta-analysis

Lorraine Lok-Wing Chiang, Shek Long Tsang, Jing Xian Lee, Mengqi Gong, Tong Liu, Gary Tse, Dong Chang, Ishan Lakhani, Ka Hou Christien Li

Open Access

Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors

Davide Margonato, Giuseppe Galati, Simone Mazzetti, Rosa Cannistraci, Gianluca Perseghin, Alberto Margonato, Andrea Mortara

Hospitalizations in adult patients with congenital heart disease: an emerging challenge

Despoina Ntiloudi, Konstantinos Dimopoulos, Aphrodite Tzifa, Haralambos Karvounis, George Giannakoulas

Hemodynamic effects of ivabradine use in combination with intravenous inotropic therapy in advanced heart failure

Mohammed Elzeneini, Juan M. Aranda Jr, Mohammad Al-Ani, Mustafa M. Ahmed, Alex M. Parker, Juan R. Vilaro

Zur Zeit gratis COVID-19

Mechanisms of COVID-19-induced heart failure: a short review

Ernest A. Adeghate, Nabil Eid, Jaipaul Singh

Zur Zeit gratis COVID-19

Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure

Iman Razeghian-Jahromi, Mohammad Javad Zibaeenezhad, Zhibing Lu, Elyaspour Zahra, Razmkhah Mahboobeh, Vicenzo Lionetti

Cardiac complications in inherited mitochondrial diseases

Mohaddeseh Behjati, Mohammad Reza Sabri, Masood Etemadi Far, Majid Nejati

Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection

Marina Rankovic, Nevena Jeremic, Ivan Srejovic, Katarina Radonjic, Aleksandra Stojanovic, Milos Glisic, Stefani Bolevich, Sergey Bolevich, Vladimir Jakovljevic

Correction

Correction to: Vitamin c: historical perspectives and heart failure

Akshi Malik, Ashim K. Bagchi, Kartik Vinayak, Gauri Akolkar, Jan Slezak, Adriane Belló-Klein, Davinder S. Jassal, Pawan K. Singal

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.